Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a population pharmacokinetic model and optimal dosing regimen of leflunomide in Korean population

Published:2023-05 Issue: Volume:184 Page:106402
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Shin Yesong,Chae Dongwoo,Park Kyungsoo^ORCID

Funder

Yonsei University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference27 articles.

1. Leflunomide, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury,2012

2. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study;Aletaha;Ann. Rheum. Dis.,2003

3. Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis;Bohanec Grabar;Drug Metab. Dispos.,2009

4. Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis;Chan;Br. J. Clin. Pharmacol.,2005

5. Efficacy and safety of leflunomide in DMARD-naive patients with early rheumatoid arthritis: comparison of a loading and a fixed-dose regimen;Cutolo;Rheumatology (Oxford),2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP